Exceeding 35,000ft², the new facility features an expanded class 10,000 clean room which is designed for manufacturing Finesse single use sensors.
The building also includes an expanded floor space for assembling and integrating single use bioreactor systems up to 2,000L and designated areas outfitted for factory acceptance testing.
In addition, an expanded space which has been allocated for research and development allows the company to further expand its product offerings to manufacturers of biologics.
Finesse Solutions CEO Barbara Paldus said over the past three years, the company has tripled its revenue and expanded its business from large-scale single-use cGMP systems to flexible laboratory bioreactor controllers.
"We are pleased to announce that our new facility provides the capacity required to meet the ever increasing demand for our growing family of products," Paldus added.